Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 5.08 HKD -3.97% Market Closed
Market Cap: 4.1B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Ocumension Therapeutics
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ocumension Therapeutics
Selling, General & Administrative Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Ocumension Therapeutics
HKEX:1477
Selling, General & Administrative
-ÂĄ422.7m
CAGR 3-Years
-14%
CAGR 5-Years
-117%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Selling, General & Administrative
-ÂĄ4.3B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Selling, General & Administrative
-ÂĄ1.1B
CAGR 3-Years
-3%
CAGR 5-Years
-12%
CAGR 10-Years
-16%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Selling, General & Administrative
-ÂĄ10.4B
CAGR 3-Years
9%
CAGR 5-Years
-3%
CAGR 10-Years
-10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Selling, General & Administrative
-ÂĄ6.2B
CAGR 3-Years
-3%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Selling, General & Administrative
-ÂĄ361.7m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ocumension Therapeutics's Selling, General & Administrative?
Selling, General & Administrative
-422.7m CNY

Based on the financial report for Dec 31, 2023, Ocumension Therapeutics's Selling, General & Administrative amounts to -422.7m CNY.

What is Ocumension Therapeutics's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-117%

Over the last year, the Selling, General & Administrative growth was -13%. The average annual Selling, General & Administrative growth rates for Ocumension Therapeutics have been -14% over the past three years , -117% over the past five years .

Back to Top